Bio-Rad
In Mason Hawkins's portfolio · Longleaf Partners
Ticker BIO
Not in the portfolio as of Q3 2026. Every quarter it shows up in a Longleaf Partners 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q2 2026 | Sell | 0 | |
| Q1 2026 | Reduce 28% | 162,804 | 2.2% |
| Q4 2025 | Reduce 4% | 227,630 | 3.1% |
| Q3 2025 | Reduce 25% | 237,254 | 3.4% |
| Q2 2025 | Reduce 3% | 315,285 | 3.8% |
| Q1 2025 | Add 5% | 323,805 | 4.2% |
| Q4 2024 | Reduce 3% | 308,469 | 4.8% |
| Q3 2024 | Reduce 2% | 318,336 | 5.0% |
| Q2 2024 | Reduce 6% | 325,013 | 3.9% |
| Q1 2024 | Reduce 6% | 343,959 | 4.6% |
| Q4 2023 | Add 12% | 364,058 | 4.5% |
| Q3 2023 | No change | 326,102 | 4.3% |
| Q2 2023 | Buy | 325,519 | 4.4% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.